Stage II Ovarian Cancer: Elizabeth's Survivor Story

Patient Info: Elizabeth Jardinella, Female, Under 40 | Stage II

Cancer-free for about 2 years, with surveillance scans continuing to show no evidence of disease while she takes maintenance letrozole.

MD AndersonRead more →

Early-stage ovarian squamous cell carcinoma arising in a mature cystic teratoma

Patient Info: Anonymized, female, 50s | Stage I

Biomarkers: ovarian tumor HPV DNA-negative; p16-negative

She achieved complete remission and had no evidence of recurrence 24 months after surgery, at follow-up in June 2026.

PubMed CentralRead more →

Stage III Triple-Negative Breast Cancer: Stephanie's Survivor Story

Patient Info: Stephanie, Female | Stage III

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1 mutation

As of June 2026, Stephanie described being a 10-year survivor after Stage III BRCA1-positive triple-negative breast cancer, with remission shown after chemotherapy and no recurrence described.

The Patient StoryRead more →

Stage II Ovarian Squamous Cell Carcinoma: Caitlin's Survivor Story

Patient Info: Caitlin Koehler, female, Under 40 | Stage II

Biomarkers: PD-L1: high expression

After surgery for recurrence, Caitlin remained on maintenance therapy and her follow-up scans showed no evidence of disease.

MD AndersonRead more →

Metastatic invasive lobular breast cancer with stomach, ovarian, peritoneal, rectal, and jejunal spread

Patient Info: Anonymized, Female, 40s | Stage IV

Biomarkers: Primary tumor and gastric metastasis were ER/PR positive and HER2 negative; GATA3 supported breast origin in the metastasis.

Metastatic Site: stomach; ovaries; peritoneum; rectum; jejunum

During 2025, she remained under active oncologic management for metastatic invasive lobular breast cancer with gastrointestinal, ovarian, peritoneal, rectal, and jejunal involvement.

PubMed CentralRead more →

Ovarian Cancer Remission Before Zolpidem Withdrawal Delirium

Patient Info: Anonymized, female

The ovarian cancer had not recurred for about 6 years, and she remained in remission.

PubMed CentralRead more →

Breast Cancer Discovered After Widespread Bone Metastases

Patient Info: Anonymized, female, 40s | Stage IV

Biomarkers: ER 90–95%; PR 90–95%; HER2 IHC 0; Ki-67 5%; germline BRCA1/2 negative

Metastatic Site: bone, bone marrow

She was receiving ongoing letrozole and ribociclib for Stage IV hormone receptor-positive, HER2-negative breast cancer with diffuse bone involvement.

PubMed CentralRead more →

Ovarian Clear Cell Cancer Developing From Endometriosis During Pregnancy

Patient Info: Anonymized, female, Under 40

Biomarkers: Napsin A positive; Ki-67 about 20%

A 33-year-old pregnant woman had ovarian clear cell carcinoma develop from a previously observed endometriotic cyst and underwent unilateral ovary-and-tube removal.

PubMed CentralRead more →

Stage I Breast Cancer: Angela's Patient Story

Patient Info: Angela George, Female, 40s | Stage I

Biomarkers: Not explicitly reported; Herceptin was given

As of September 2025, Angela was approaching 5 years from her Stage I breast cancer diagnosis, had completed bilateral mastectomy, chemotherapy, Herceptin, and oophorectomy, and remained on daily estrogen-reducing medication with oncology visits every 6 months; the source does not explicitly state NED.

Cleveland ClinicRead more →

Advanced high-grade serous ovarian cancer with treatment-resistant progression and hyperprolactinemia

Patient Info: Anonymized, Female, 50s

Biomarkers: BRCA1 variant of uncertain significance

The ovarian cancer continued to progress despite multiple treatments, and she died 2.5 years after the ovarian-cancer diagnosis.

PubMed CentralRead more →

Stage 4 breast cancer: complete remission with letrozole and palbociclib

Patient Info: Anonymized, Female | Stage IV

Biomarkers: Breast cancer was ER/PR positive, HER2 0

Metastatic Site: pleura/pleural effusion

Breast cancer remained in remission on letrozole after palbociclib was stopped; Ph-positive B-ALL achieved complete response with no molecular residual disease after blinatumomab plus ponatinib, with ongoing monthly outpatient monitoring.

PubMed CentralRead more →

Young woman with familial adenomatous polyposis and metastatic colorectal cancer

Patient Info: Anonymized, Female, Under 40 | Stage IV

Metastatic Site: left ovary

She completed 12 rounds of FOLFOX and was doing well during ongoing follow-up with imaging and laboratory monitoring.

PubMed CentralRead more →

Ovarian cancer lung metastasis followed by a benign staple-line granuloma

Patient Info: Anonymized, Female, 40s | Stage IV

Metastatic Site: lung

More than 10 years after her original ovarian-cancer surgery, a mass near the prior lung-metastasis staple line was surgically removed and proved to be a benign epithelial granuloma rather than recurrent cancer.

PubMed CentralRead more →

Invasive Lobular Carcinoma: Brenda's Survivor Story

Patient Info: Brenda, Female, 40s

Brenda completed mastectomy, chemotherapy, radiation and an oophorectomy. She remained on anastrozole and a CDK4/6 inhibitor when she shared her story.

Lobular Breast Cancer AllianceRead more →

Stage IV PIK3CA Breast Cancer: Abigail's Patient Story

Patient Info: Abigail, Female, Under 40 | Stage IV

Biomarkers: Hormone-positive breast cancer with PIK3CA mutation and germline ATM mutation; later PD-L1 somatic change reported. HER2 not stated.

Metastatic Site: Bone, including femurs, spine, and humeri; later liver

As of October 2022, Abigail was living with Stage IV hormone-positive metastatic breast cancer after years of treatment, bone-dominant disease that later involved the liver, targeted therapies, genomic testing, and advocacy around clinical trials and patient research participation.

The Patient StoryRead more →

Invasive Lobular Carcinoma: Eileen's Survivor Story

Patient Info: Eileen, Female

As of March 2022, Eileen described herself as having no evidence of disease after double mastectomy, multiple surgeries for necrosis complications, and oophorectomy with benign biopsy findings, while continuing 4-month oncology follow-up.

Lobular Breast Cancer AllianceRead more →

Stage III Breast Cancer: Aalia's Survivor Story

Patient Info: Aalia, Female, 40s | Stage III

As of 2022, Aalia had completed treatment for Stage III breast cancer, was no longer taking medication, and was focused on recovery, family, and fear-of-recurrence support.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Carmen's Survivor Story

Patient Info: Carmen, Female, 50s | Stage III

Carmen was declared cancer-free in February 2023 after surgery and follow-up examinations, while continuing hormone therapy and pain medication.

Our Cancer StoriesRead more →

Severe immune thrombocytopenia during treatment for metastatic colon cancer

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: KRAS-mutated; microsatellite stable; BRAF-wild type.

Metastatic Site: bilateral ovaries; pelvis; peritoneum; mesenteric…

After multiple metastatic recurrences and treatment changes, she died from progressive colon cancer; oxaliplatin had been permanently stopped after antibody-confirmed immune thrombocytopenia.

PubMed CentralRead more →

Ovarian Wilms tumor arising in a mature cystic teratoma

Patient Info: Anonymized, Female, Under 40

Biomarkers: WT1-positive; PAX8-positive

After the diagnosis was revised to ovarian Wilms tumor, she was advised to see a gynecologic oncologist but did not return for follow-up.

PubMed CentralRead more →

Ovarian Wilms tumor with early abdominal recurrence

Patient Info: Anonymized, Female, Under 40

Biomarkers: WT1-positive; residual tumor MyoD1-positive

After 3 months of radiation and a further 3 months of chemotherapy, PET showed no FDG-avid malignancy.

PubMed CentralRead more →

A uterine mass revealed a rare metastasis from lung adenocarcinoma

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: CK7-positive; TTF-1-positive; CK20-negative; PAX8-negative; GATA3-negative.

Metastatic Site: uterus within a leiomyoma

Twelve months after removal of the uterine metastasis, she remained well with normal surveillance imaging and no concern for recurrent disease.

PubMed CentralRead more →

Stage IV Breast Cancer: Janet's Survivor Story

Patient Info: Janet Klein, Female | Stage IV

Metastatic Site: Bone: left iliac bone

Janet’s Stage 1 breast cancer later recurred and metastasized to the left iliac bone, but she had no sign of cancer from January 2010 onward while continuing palbociclib plus letrozole.

Stage II HR-Positive Breast Cancer: Cath's Survivor Story

Patient Info: Cath, Female, 60s | Stage II

Biomarkers: ER-positive; PR-positive; HER2-negative

Cath was declared cancer-free in June 2024 after Stage II luminal A ER-positive/PR-positive/HER2-negative breast cancer treated with surgery, radiation, and hormone therapy, though she continued to manage long-term side effects and recurrence fear.

Our Cancer StoriesRead more →